Skip to main content
. 2018 Jul 17;19(7):2077. doi: 10.3390/ijms19072077

Figure 8.

Figure 8

Radioiodine uptake in thyroid carcinoma (TC) cells after treatment with selumetinib. BCPAP, 8505C, C643 and TPC1 cell lines were treated for 48 h with 10 µM selumetinib and 1 MBql I-13. The radioactivity of cells was measured on a gamma counter. Data represent mean ± SEM of experiments performed in triplicates. * p < 0.05 regarded as significant.